Gain Therapeutics Stock Market Value
| GANX Stock | USD 1.47 0.03 2.08% |
| Symbol | Gain |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gain Therapeutics. If investors know Gain will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gain Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Gain Therapeutics is measured differently than its book value, which is the value of Gain that is recorded on the company's balance sheet. Investors also form their own opinion of Gain Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gain Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gain Therapeutics' market value can be influenced by many factors that don't directly affect Gain Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gain Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gain Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gain Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gain Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gain Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gain Therapeutics.
| 05/07/2025 |
| 08/05/2025 |
If you would invest 0.00 in Gain Therapeutics on May 7, 2025 and sell it all today you would earn a total of 0.00 from holding Gain Therapeutics or generate 0.0% return on investment in Gain Therapeutics over 90 days. Gain Therapeutics is related to or competes with Coya Therapeutics,, Cue Biopharma, Lantern Pharma, Fennec Pharmaceuticals, and Climb Bio. Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by pr... More
Gain Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gain Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gain Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 23.83 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.51 |
Gain Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gain Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gain Therapeutics' standard deviation. In reality, there are many statistical measures that can use Gain Therapeutics historical prices to predict the future Gain Therapeutics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.33) |
Gain Therapeutics Backtested Returns
Gain Therapeutics holds Efficiency (Sharpe) Ratio of -0.0833, which attests that the entity had a -0.0833 % return per unit of risk over the last 3 months. Gain Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gain Therapeutics' Market Risk Adjusted Performance of (0.32), risk adjusted performance of (0.06), and Standard Deviation of 4.34 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.14, which attests to a somewhat significant risk relative to the market. Gain Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Gain Therapeutics is expected to follow. At this point, Gain Therapeutics has a negative expected return of -0.36%. Please make sure to check out Gain Therapeutics' value at risk, as well as the relationship between the rate of daily change and relative strength index , to decide if Gain Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.39 |
Below average predictability
Gain Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Gain Therapeutics time series from 7th of May 2025 to 21st of June 2025 and 21st of June 2025 to 5th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gain Therapeutics price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Gain Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Gain Therapeutics lagged returns against current returns
Autocorrelation, which is Gain Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gain Therapeutics' stock expected returns. We can calculate the autocorrelation of Gain Therapeutics returns to help us make a trade decision. For example, suppose you find that Gain Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gain Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gain Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gain Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gain Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Gain Therapeutics Lagged Returns
When evaluating Gain Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gain Therapeutics stock have on its future price. Gain Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gain Therapeutics autocorrelation shows the relationship between Gain Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Gain Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.